Use symptom timing, CT and CSF together to assess subarachnoid bleeding, then distinguish rebleeding, delayed ischemia, hydrocephalus and other complications.
A normal scan and a bloody lumbar puncture are not opposites. Each result answers a different question at a different time. The central decision is whether blood entered the subarachnoid space before the needle entered the back.
By the end, explain when a negative CT is reassuring, what bilirubin adds to a red-cell count, and why a patient can deteriorate after the aneurysm has been treated. First establish the diagnosis, then separate the source of bleeding from problems with perfusion, cerebrospinal fluid circulation and systemic physiology.
How quickly did the headache become severe?
Time to peak is more useful than the phrase worst headache. A thunderclap reaches maximum intensity in less than a minute. Subarachnoid hemorrhage (SAH) is a critical cause, but thunderclap is a presentation, not a final diagnosis. An initially normal examination does not make it benign. [1][8]
A ruptured saccular aneurysm is an important cause of spontaneous SAH; nonaneurysmal and traumatic causes also exist. Arterial blood entering the cerebrospinal fluid (CSF) spaces can abruptly increase intracranial pressure and irritate the meninges. Associated findings include collapse or syncope, vomiting, neck stiffness, photophobia, seizures and focal deficits. Not every patient has all of them, and meningism may be absent early. A prior abrupt, unexplained headache can represent a warning leak even if it improved. [1][2]
Compare onset, not just intensity
One patient develops familiar unilateral pain gradually, with nausea and light sensitivity. Another becomes maximally symptomatic during a single sentence and briefly loses consciousness. Both may report severe pain, but the second time course requires urgent investigation for a vascular emergency. Migraine usually builds gradually; tension-type pain is commonly pressing and bilateral; cervicogenic pain relates to neck dysfunction. None of those labels safely explains a new thunderclap without investigation. [2][8]
Before reading the response, identify the feature that would still concern you after the second patient's pain improves.
Check the inference
The abrupt peak and loss of consciousness remain concerning. Improvement after time or analgesia does not retrospectively exclude bleeding. [1][2]
Other important causes include reversible cerebral vasoconstriction syndrome, cerebral venous thrombosis, cervical arterial dissection and pituitary apoplexy. Venous thrombosis is not excluded just because the pain was sudden. Primary thunderclap headache is a diagnosis of exclusion; early vascular imaging can also be normal in reversible cerebral vasoconstriction syndrome. [8]
Transfer: A history of migraine changes the background history, not the meaning of a new instantly peaking attack. Stabilize airway, breathing and circulation when necessary and obtain urgent diagnostic evaluation rather than treating the familiar diagnosis by default. [1][2]
A negative CT needs a clock and a clinical context
Noncontrast head CT looks for blood already present; angiography looks for its vascular source. Acute blood can appear bright within basal cisterns and fissures. A CT demonstrating subarachnoid blood establishes SAH without a confirmatory lumbar puncture. In the clinical image accompanying this section, trace the bright central material around the midbrain rather than the white outer skull. This real example shows blood in the basal cisterns; it does not, by itself, identify which aneurysm ruptured. [1][2]
Trace the central cisternal hyperattenuation rather than the white skull. The scan shows subarachnoid blood but does not identify its arterial source. Image: Lipothymia, Wikimedia Commons, CC BY-SA 3.0; Lipothymia; original source; CC BY-SA 3.0. [1][2].
Blood becomes harder to detect as it disperses and is cleared. A high-quality scan within six hours, with a reliable onset time, no new neurological deficit and an expert interpretation, can support exclusion without routine lumbar puncture. Scanner quality, interpretation, anemia and the actual presentation matter. Do not apply that pathway to an uncertain onset or a technically limited study. [1][2]
Same negative report, different meaning
Clinical setting
Interpretation
Clinical settingFour hours; normal neurological examination; reliable expert-read study
InterpretationThe early CT pathway may be sufficient after clinical assessment.
Clinical settingFour hours; new focal deficit or inadequate study
InterpretationThe reassuring early pathway does not apply.
Clinical settingFourteen hours; sudden severe onset remains unexplained
InterpretationFurther investigation is needed despite a negative scan.
Trace the two timing tracks in the diagram. When blood becomes less conspicuous on CT, does its breakdown product become less useful at exactly the same rate?
CT blood and CSF bilirubin follow different time courses. This is not a numerical sensitivity plot. Early CT exclusion is conditional; the NICE bilirubin pathway uses at least twelve hours. [1][2][4]Compare the two tracks
No. Visible blood can diminish while bilirubin has had time to accumulate. CT and CSF are complementary tests, not interchangeable clocks. [2][4]
For a concerning presentation beyond six hours or with a new deficit, AHA/ASA recommends CT followed by lumbar puncture when CT is negative, subject to procedural safety. Some emergency pathways use CT angiography (CTA) after discussion of its benefits and limitations. CTA may reveal an incidental unruptured aneurysm, and a negative CTA is not direct proof that no hemorrhage occurred. A patient with instability or a contraindication to lumbar puncture needs urgent specialist-directed alternatives, not delayed resuscitation. [1][2]
Once SAH is confirmed, obtain prompt vascular imaging and specialist involvement. If CTA is negative or inconclusive but concern for an aneurysmal source remains high, digital subtraction angiography (DSA) is indicated. Endovascular coiling or surgical clipping is selected by the treating specialists and should occur as early as feasible, preferably within 24 hours, rather than waiting routinely for 24 to 48 hours. Stabilization and preventive medical care proceed in parallel. [1][2]
Transfer: A scan performed today cannot be called a four-hour scan because the patient arrived four hours ago. Calculate the interval from symptom onset to image acquisition. [1][2]
Separate cells, pigments and sample handling
A red-cell count records cells in the tube; bilirubin can record blood breakdown that occurred inside the patient. After bleeding, red cells break down, releasing hemoglobin. Subsequent metabolism produces bilirubin. Centrifugation separates intact cells into a pellet but does not eliminate dissolved pigment from the supernatant. [4]
Xanthochromia describes discoloration, but a visual report of pink fluid is not equivalent to a specific bilirubin result. Oxyhemoglobin may form after a traumatic collection or delayed processing; bilirubin interpretation also needs consideration of serum bilirubin and CSF protein. Follow the laboratory's collection protocol, promptly centrifuge the sample and protect it from light. Spectrophotometry distinguishes pigment patterns more objectively than eye inspection. [4]
Timing is essential. In the NICE bilirubin-based pathway, obtain CSF at least 12 hours after symptom onset to allow sufficient bilirubin formation. An earlier negative bilirubin result is not an independent exclusion test. This timing instruction does not justify delaying emergency imaging, resuscitation or specialist consultation. Bilirubin may persist after CT conspicuity has decreased; the laboratory method and clinical interval still govern interpretation. [2][4]
Trace what survives the centrifuge
Use the paired-tube diagram. In the first pair, blood was present in CSF before collection; in the second, fresh blood entered during collection. Point to the part that forms a pellet, then to the part that can remain dissolved. Predict what changes if the second sample sits unprocessed.
The centrifuge separates intact cells from fluid, not earlier bleeding from needle trauma. Delayed processing can release oxyhemoglobin, so pink fluid is not proof of bilirubin. [3][4]First inference: intact cells
Intact red cells sediment into a pellet in either sample. A pellet therefore cannot tell when blood entered the fluid. [4]
Second inference: dissolved pigment
Bilirubin formed in the patient can remain in the supernatant. Fresh blood left in a tube can instead release oxyhemoglobin, creating a misleading visual color. [4]
The complete comparison is visible in the diagram: collection history affects cells; elapsed biological time and handling affect pigments. Neither the color nor a single cell count should be interpreted without those conditions.
A falling red-cell count from tube 1 to tube 4 does not safely exclude SAH. A traumatic puncture and a real hemorrhage can coexist. Persistent red cells also do not prove an aneurysm. Use the final-tube count, bilirubin or xanthochromia method, symptom timing and clinical probability together. Counts are expressed here as cells per microliter, not per milliliter. [3][4]
In a prospective cohort of selected alert patients with acute headache, fewer than 2,000 red cells/µL in the final tube plus no xanthochromia identified a low-risk group for aneurysmal SAH. This is a combined finding from a particular study, not a universal threshold for every patient or every cause of hemorrhage. The study's sensitivity estimate had a wide confidence interval. A count at or above that boundary is not itself proof of SAH. [3]
Transfer: A patient has 12,000 red cells/µL in tube 1 and 3,000 in tube 4. The decline is real, but it neither meets that low-count combination nor cancels a concerning thunderclap history. Do not substitute percentage clearing for the complete evaluation. [3]
Clinical severity and blood burden answer different questions
Examine the patient and examine the scan separately. Hunt and Hess describes clinical condition. Imaging-based scales describe blood distribution and risk. An alert person with extensive blood still needs urgent treatment and surveillance; a poor clinical grade should not alone determine transfer or limitation of care. Sedation, seizures and hydrocephalus can confound the examination. [1][2][6]
Hunt and Hess: a clinical description, not a treatment gate
Grade
Typical clinical features
GradeI
Typical clinical featuresAsymptomatic or mild headache with slight neck stiffness
GradeII
Typical clinical featuresModerate to severe headache and neck stiffness; no deficit except a cranial nerve palsy
GradeIII
Typical clinical featuresDrowsiness, confusion or a mild focal deficit
GradeIV
Typical clinical featuresStupor with moderate to severe hemiparesis; possible early decerebrate signs
GradeV
Typical clinical featuresDeep coma with decerebrate rigidity or a moribund appearance
The modified Fisher scale adds intraventricular hemorrhage (IVH) to subarachnoid blood thickness: 0, neither SAH nor IVH; 1, thin SAH without IVH; 2, thin SAH with IVH; 3, thick SAH without IVH; 4, thick SAH with IVH. Thick blood generally means a clot at least 1 mm thick in this grading convention. Use the radiologist's complete assessment rather than estimating from a single selected image. [1][6]
This is not the same as the original Fisher scale. Original Fisher grade 4 groups intraventricular or intracerebral clot with absent or diffuse SAH; its risk does not rise neatly from 1 through 4. The modified scale was developed to better incorporate the importance of ventricular blood. Do not silently substitute one system for the other. [6]
Consider two alert patients with severe headache. One has thin cisternal blood without IVH; the other has thick cisternal blood and IVH. Which measurement changes even though their clinical descriptions match?
Compare the risk descriptions
The modified Fisher grade differs: 1 versus 4. Similar bedside alertness does not imply similar radiographic blood burden. [6]
Transfer: A formerly alert patient who becomes drowsy needs an explanation for that change, not merely a new grade in the chart. Recheck sedatives, glucose, oxygenation, imaging and other reversible causes while escalating care. [1]
Preserve perfusion without confusing narrowing with ischemia
Vasospasm describes arterial narrowing; delayed cerebral ischemia (DCI) describes delayed ischemic injury or clinical deterioration after other explanations are assessed. They overlap but are not synonyms. DCI is multifactorial, so a normal large-vessel study does not exclude every ischemic mechanism, and narrowing without a new deficit does not establish clinical DCI. [1][9]
The higher-risk period is approximately days 3 through 14 after hemorrhage, with large-vessel spasm often most prominent around the end of the first week. These are overlapping biological periods, not appointments. Rebleeding, hydrocephalus, infection, metabolic disturbances and seizures can occur during the same interval. [1][9]
Early enteral nimodipine improves neurological outcomes. A usual adult regimen is 60 mg every four hours for 21 days, begun within 96 hours under the product label and started early in clinical care. Its benefit is not established by showing that an angiographic narrowing has disappeared. The oral solution is for the mouth, nasogastric tube or gastric tube, never intravenous administration. Monitor hypotension and interacting medicines; cirrhosis requires label-directed dose reduction. [1][7]
Follow serial neurological examinations. Transcranial Doppler provides useful velocity trends, while CTA and CT perfusion can assess vascular narrowing and tissue perfusion when deterioration or a limited examination creates concern. Velocity reflects more than diameter, and neither a single high nor a single normal value replaces the clinical assessment. [1]
Compare a narrow artery with its downstream tissue
In the perfusion diagram, trace blood through a narrowed segment. Then compare the downstream tissue in a patient who remains normal with that of a patient who develops weakness and a matching perfusion abnormality. Identify the extra evidence needed before treating an image as symptomatic ischemia.
Match deficits to perfusion evidence and assess competing causes. Arterial narrowing alone is not clinical DCI, and not every DCI mechanism requires large-vessel narrowing. [1][9]Read the downstream finding
A new compatible deficit plus evidence of impaired perfusion, after competing causes are assessed, makes the narrowing clinically consequential. Narrowing alone is a surveillance finding, not permission for automatic pressure augmentation. [1][9]
For suspected DCI, urgently evaluate new bleeding, ventricular enlargement, seizures, sedation and metabolic problems. In selected patients with symptomatic vasospasm or DCI, particularly after the aneurysm is secured, individualized blood-pressure augmentation may help. Maintain euvolemia rather than routinely inducing hypervolemia. Refractory severe vasospasm may require intra-arterial vasodilators or angioplasty in specialist care. Routine prophylactic hemodynamic augmentation is not recommended. [1]
Transfer: A normal Doppler result yesterday does not explain aphasia today. Reassess the patient now rather than using an earlier surveillance test as permanent clearance. [1]
When the examination changes, test competing causes
Treat deterioration as new evidence, not as the expected next stage of SAH. Early aneurysm securement reduces rebleeding risk, but it does not make later hemorrhage impossible. Abrupt recurrent pain or reduced consciousness warrants immediate reassessment and imaging. Before securement, monitor blood pressure frequently and use short-acting titratable therapy when needed; avoid severe hypertension, hypotension and large fluctuations. There is no single evidence-established pressure target for every patient. Reverse relevant anticoagulation promptly. [1]
Perfusion depends on both arterial pressure and intracranial pressure (ICP). In the simplified relationship, cerebral perfusion pressure is mean arterial pressure minus ICP. If mean arterial pressure is 90 mm Hg and ICP is 25, the difference is 65 mm Hg. Lowering mean arterial pressure to 65 without changing ICP reduces that difference to 40. This explains the hazard of indiscriminate pressure reduction; the arithmetic is a teaching model, not a universal treatment target. [1]
Obstructed CSF circulation is a different emergency
Blood can obstruct ventricular pathways or impair CSF absorption. Ventricular expansion can then worsen consciousness and increase ICP. Acute symptomatic hydrocephalus requires urgent CSF diversion, commonly through an external ventricular drain (EVD); the appropriate route depends on the anatomy and specialist assessment. Do not perform a diagnostic lumbar puncture through an unsafe pressure gradient. [1]
Trace CSF through the final diagram and identify the obstruction. Predict why lowering arterial pressure alone would not correct the enlarging ventricles.
One obstructive example shows a clot blocking CSF outflow and a ventricular drain bypassing that pressure burden. SAH can also impair absorption. This is not a placement guide. [1]Check the pressure relationship
The outflow problem persists. CSF diversion addresses the pressure burden, whereas indiscriminate arterial-pressure reduction may further reduce cerebral perfusion. [1]
Sodium is a concentration, not a volume measurement
Low serum sodium with low serum osmolality and inappropriately concentrated urine indicates impaired excretion of water relative to solute, but does not by itself distinguish syndrome of inappropriate antidiuresis (SIADH) from renal salt loss. SIADH usually has preserved extracellular volume. Cerebral salt wasting describes renal sodium loss with volume depletion. Urine sodium may be high in both. Review serial weight, intake and output, circulation, medicines, renal function and adrenal and thyroid status rather than trusting one bedside volume label. [1][10]
For comparison, negative fluid balance, falling weight and natriuresis support salt and volume loss. Stable balance and weight with concentrated urine during hypotonicity support SIADH after competing causes are excluded. Diabetes insipidus instead produces an inability to concentrate urine and tends toward hypernatremia when water is not replaced. Primary excess water intake usually permits very dilute urine. [10]
Maintain euvolemia after SAH. Reflex fluid restriction that produces volume depletion can worsen cerebral perfusion. Severe symptomatic hyponatremia needs carefully monitored hypertonic saline with frequent sodium checks and prevention of overly rapid correction; a mildly low sodium value does not automatically require that emergency treatment. Persistent natriuresis may warrant mineralocorticoid therapy under specialist supervision. [1][10]
Inflammatory CSF does not identify an organism
Fever, declining consciousness and worsening CSF inflammation in a patient with a documented EVD raise concern for healthcare-associated ventriculitis. Blood and surgery can also alter CSF white cells, protein and glucose. Obtain appropriate CSF cultures; low glucose or a negative Gram stain cannot settle the diagnosis alone. When infection is suspected, obtain cultures promptly and begin empiric therapy without waiting for results. Vancomycin plus an antipseudomonal beta-lactam such as cefepime is a standard approach, adjusted to local resistance, allergies and renal function. Common pathogens include staphylococci and gram-negative bacilli. Infected hardware also needs specialist source-control assessment. [5]
Finally, absence of visible convulsions does not exclude seizures. Continuous EEG is useful with unexplained depressed consciousness or a fluctuating examination. Treat clinical or electrographic seizures. Antiseizure prophylaxis is not routine for everyone, but can be considered with high-risk features such as high-grade SAH, intraparenchymal blood, hydrocephalus or cortical injury; phenytoin is generally avoided because of associated harm. [1]
Transfer: On day 7, ask what changed in the examination, scan, CSF drainage, sodium, medication exposure and EEG. The calendar narrows the differential; it does not make the diagnosis. [1][5][9][10]
Independent clinical practice
Case 1
Show answer and explanations for case 1
A. CT venography of the head (Why this does not fit)
Venography can detect cerebral venous thrombosis, another cause of abrupt headache. The late negative CT has not adequately addressed the suspected subarachnoid bleed; CSF analysis directly evaluates that question.
Reasoning steps for option A
What would venography investigate?
Venography can detect cerebral venous thrombosis, another cause of abrupt headache.
Which unresolved question takes priority here?
The late negative CT has not adequately addressed the suspected subarachnoid bleed; CSF analysis directly evaluates that question.
B. Repeat noncontrast CT in one week (Why this does not fit)
Repeat CT can document evolving structural abnormalities. Blood generally becomes less conspicuous with time, so delayed repeat CT is not the appropriate exclusion strategy.
Reasoning steps for option B
Why might serial CT seem useful?
Repeat CT can document evolving structural abnormalities.
Would waiting increase detection of a small earlier bleed?
Blood generally becomes less conspicuous with time, so delayed repeat CT is not the appropriate exclusion strategy.
C. Lumbar puncture with CSF analysis (Best answer)
This scan lies outside the selected early CT exclusion pathway. CSF red cells and bilirubin assessment can detect evidence of hemorrhage despite a negative later CT; the supplied findings do not identify a procedural contraindication.
Reasoning steps for option C
What does fourteen hours change?
This scan lies outside the selected early CT exclusion pathway.
What can appropriately timed CSF add?
CSF red cells and bilirubin assessment can detect evidence of hemorrhage despite a negative later CT; the supplied findings do not identify a procedural contraindication.
D. MR angiography of the head (Why this does not fit)
Angiography examines arteries and may show an aneurysm. No. An incidental aneurysm is not proof of rupture, whereas the question asks for evidence of blood in CSF.
Reasoning steps for option D
What does arterial angiography identify?
Angiography examines arteries and may show an aneurysm.
Does finding or not finding an aneurysm directly settle prior bleeding?
No. An incidental aneurysm is not proof of rupture, whereas the question asks for evidence of blood in CSF.
Takeaway: A negative late CT does not finish the assessment of a concerning thunderclap presentation.
A. The new deficit invalidates the early CT exclusion pathway (Best answer)
The patient now has a new focal neurological deficit. The reassuring early CT pathway applies to patients without a new deficit; urgent neurological and vascular evaluation remains necessary.
Reasoning steps for option A
Which eligibility condition has changed?
The patient now has a new focal neurological deficit.
How does that alter the negative CT interpretation?
The reassuring early CT pathway applies to patients without a new deficit; urgent neurological and vascular evaluation remains necessary.
B. The normal scan establishes migraine with neurological aura (Why this does not fit)
Migraine can produce headache with transient focal neurological symptoms. A new thunderclap followed by a focal deficit still requires assessment for secondary causes; normal noncontrast CT does not establish migraine.
Reasoning steps for option B
Why does migraine enter the differential?
Migraine can produce headache with transient focal neurological symptoms.
What prevents that conclusion from the scan alone?
A new thunderclap followed by a focal deficit still requires assessment for secondary causes; normal noncontrast CT does not establish migraine.
C. The normal glucose establishes a nonvascular cause of weakness (Why this does not fit)
Hypoglycemia can mimic a focal neurological event. It reduces concern for hypoglycemia but does not exclude a vascular lesion or hemorrhage missed by the scan.
Reasoning steps for option C
Why is glucose checked?
Hypoglycemia can mimic a focal neurological event.
What does this normal value actually establish?
It reduces concern for hypoglycemia but does not exclude a vascular lesion or hemorrhage missed by the scan.
D. The three-hour timing makes further testing unnecessary (Why this does not fit)
Expert-read early CT has high sensitivity in the population for which that pathway was developed. The new focal deficit places this patient outside that uncomplicated early-exclusion population.
Reasoning steps for option D
Why is early timing reassuring in selected patients?
Expert-read early CT has high sensitivity in the population for which that pathway was developed.
Which supplied finding prevents that shortcut here?
The new focal deficit places this patient outside that uncomplicated early-exclusion population.
Takeaway: Check the population and examination, not the clock alone, before applying a rule-out pathway.
A. Lumbar puncture for bilirubin measurement (Why this does not fit)
It can support hemorrhage when a concerning presentation has a negative CT. Blood is already demonstrated in the subarachnoid spaces; the remaining task is to identify and treat its source.
Reasoning steps for option A
When can CSF bilirubin be useful?
It can support hemorrhage when a concerning presentation has a negative CT.
Why is it unnecessary for the immediate question?
Blood is already demonstrated in the subarachnoid spaces; the remaining task is to identify and treat its source.
B. CT venography for venous outflow mapping (Why this does not fit)
Venous thrombosis can cause headache and sometimes subarachnoid bleeding. Diffuse basal cisternal and sylvian blood directs the immediate investigation toward an arterial aneurysm.
Reasoning steps for option B
Why consider venous imaging in some headaches?
Venous thrombosis can cause headache and sometimes subarachnoid bleeding.
Why is it not the first source study for this pattern?
Diffuse basal cisternal and sylvian blood directs the immediate investigation toward an arterial aneurysm.
C. Transcranial Doppler for flow-velocity measurement (Why this does not fit)
Doppler trends can assist surveillance for vasospasm after hemorrhage. It does not reliably define the ruptured aneurysm anatomy needed for coiling or clipping.
Reasoning steps for option C
What clinical role does Doppler serve?
Doppler trends can assist surveillance for vasospasm after hemorrhage.
Would it supply the required treatment anatomy?
It does not reliably define the ruptured aneurysm anatomy needed for coiling or clipping.
D. CT angiography for intracranial arterial anatomy (Best answer)
Blood in the described subarachnoid spaces establishes SAH without a confirmatory puncture. CTA can identify the arterial source and help the team select prompt aneurysm securement.
Reasoning steps for option D
What has the noncontrast scan established?
Blood in the described subarachnoid spaces establishes SAH without a confirmatory puncture.
What additional information guides definitive treatment?
CTA can identify the arterial source and help the team select prompt aneurysm securement.
Takeaway: After CT establishes SAH, image the vessels to identify the source rather than repeating confirmation of blood.
A. Repeat lumbar puncture for bilirubin (Why this does not fit)
It would provide evidence of blood breakdown in CSF. Hemorrhage is already established on CT; the unresolved question is the arterial source.
Reasoning steps for option A
What would bilirubin assess?
It would provide evidence of blood breakdown in CSF.
What question is still unresolved?
Hemorrhage is already established on CT; the unresolved question is the arterial source.
B. Catheter digital subtraction angiography (Best answer)
A small or otherwise occult aneurysm may still be present despite a satisfactory CTA. DSA supplies a more detailed vascular evaluation when confirmed SAH and its distribution maintain high concern for an aneurysm.
Reasoning steps for option B
What does the negative CTA leave unresolved?
A small or otherwise occult aneurysm may still be present despite a satisfactory CTA.
Why use catheter angiography in this setting?
DSA supplies a more detailed vascular evaluation when confirmed SAH and its distribution maintain high concern for an aneurysm.
C. Daily transcranial Doppler surveillance (Why this does not fit)
It can track flow changes associated with vasospasm. It does not settle the unresolved aneurysm source before definitive treatment planning.
Reasoning steps for option C
Why will Doppler matter during admission?
It can track flow changes associated with vasospasm.
Why is surveillance not enough now?
It does not settle the unresolved aneurysm source before definitive treatment planning.
D. Brain EEG with continuous recording (Why this does not fit)
It can detect nonconvulsive seizures in a patient with unexplained altered consciousness. The supplied problem is unexplained arterial-pattern bleeding after CTA, not an unexplained fluctuating examination.
Reasoning steps for option D
When would continuous EEG help?
It can detect nonconvulsive seizures in a patient with unexplained altered consciousness.
Why does it not answer this lead-in?
The supplied problem is unexplained arterial-pattern bleeding after CTA, not an unexplained fluctuating examination.
Takeaway: A negative CTA does not end aneurysm evaluation when confirmed SAH and its distribution sustain high suspicion.
A. The decline in cells leaves hemorrhage unresolved (Best answer)
Yes, but collection trauma can coexist with blood already present in CSF. The late CT and remaining 3,000 red cells/µL do not provide a low-risk combined result, and visual inspection does not replace the pending pigment assessment.
Reasoning steps for option A
Can collection trauma produce a falling count?
Yes, but collection trauma can coexist with blood already present in CSF.
What prevents closure of the evaluation?
The late CT and remaining 3,000 red cells/µL do not provide a low-risk combined result, and visual inspection does not replace the pending pigment assessment.
B. The decline in cells supports ending the evaluation (Why this does not fit)
Needle-related bleeding can decrease as successive tubes are collected. Clearing alone has not safely excluded SAH, especially with a persistent substantial final-tube count and a concerning onset.
Reasoning steps for option B
Why might a falling count reassure the clinician?
Needle-related bleeding can decrease as successive tubes are collected.
Why is that insufficient in this patient?
Clearing alone has not safely excluded SAH, especially with a persistent substantial final-tube count and a concerning onset.
C. The first-tube count establishes an aneurysmal source (Why this does not fit)
Many red cells are present in that sample. No. Red cells can result from collection trauma or hemorrhage and do not identify a vascular source.
Reasoning steps for option C
What does a high first-tube count establish?
Many red cells are present in that sample.
Can the count identify an aneurysm?
No. Red cells can result from collection trauma or hemorrhage and do not identify a vascular source.
D. The absence of yellow color favors excluding bleeding (Why this does not fit)
Blood-breakdown pigments can discolor the fluid. Visual absence of yellow color is not equivalent to a completed laboratory bilirubin assessment or an adequate combined exclusion pathway.
Reasoning steps for option D
Why is supernatant color examined?
Blood-breakdown pigments can discolor the fluid.
Why does the reported appearance not settle this case?
Visual absence of yellow color is not equivalent to a completed laboratory bilirubin assessment or an adequate combined exclusion pathway.
Takeaway: Falling counts do not cancel a high-risk presentation; interpret final-tube cells and pigments together.
A. The sample establishes needle trauma as the source (Why this does not fit)
A lumbar puncture can introduce blood during collection. No. The combined result addressed risk of aneurysmal SAH, not proof that all detected blood came from the needle.
Reasoning steps for option A
Why could trauma account for red cells?
A lumbar puncture can introduce blood during collection.
Did the study identify the origin of every red cell?
No. The combined result addressed risk of aneurysmal SAH, not proof that all detected blood came from the needle.
B. The result excludes every secondary headache disorder (Why this does not fit)
The combination was associated with low risk for the studied hemorrhagic outcome. No. Disorders such as venous thrombosis or arterial dissection are outside the specific aneurysmal-SAH outcome.
Reasoning steps for option B
Why could the negative workup reduce concern?
The combination was associated with low risk for the studied hemorrhagic outcome.
Does that cover all secondary headache causes?
No. Disorders such as venous thrombosis or arterial dissection are outside the specific aneurysmal-SAH outcome.
C. The result supports low risk in a comparable patient (Best answer)
The final count is below 2,000/µL and xanthochromia is absent. It supports the study-defined low-risk interpretation in an appropriate clinical pathway, not universal certainty in unstudied populations.
Reasoning steps for option C
Which tested combination is present?
The final count is below 2,000/µL and xanthochromia is absent.
How far can that result be generalized?
It supports the study-defined low-risk interpretation in an appropriate clinical pathway, not universal certainty in unstudied populations.
D. The first-tube count is needed to calculate clearance (Why this does not fit)
A changing count may suggest a component of collection-related bleeding. No. The cited approach uses the final-tube count together with xanthochromia, not a mandatory percentage decline.
Reasoning steps for option D
Why is a first-to-last comparison tempting?
A changing count may suggest a component of collection-related bleeding.
Was percentage clearance the required combined rule?
No. The cited approach uses the final-tube count together with xanthochromia, not a mandatory percentage decline.
Takeaway: Use a diagnostic threshold for its actual outcome and population, not as proof of a different diagnosis.
A. The pink color identifies bilirubin formed before collection (Why this does not fit)
Breakdown of blood within the patient can produce bilirubin. The laboratory identifies oxyhemoglobin rather than bilirubin, so pink appearance alone does not establish in-vivo bilirubin formation.
Reasoning steps for option A
Why can prior hemorrhage discolor CSF?
Breakdown of blood within the patient can produce bilirubin.
Does this reported pigment match that conclusion?
The laboratory identifies oxyhemoglobin rather than bilirubin, so pink appearance alone does not establish in-vivo bilirubin formation.
B. The processing delay permits an in-vitro source of oxyhemoglobin (Best answer)
Red cells remained in the uncentrifuged specimen for four hours. Lysis can release oxyhemoglobin after collection; that possibility prevents the pigment alone from proving a pre-existing bleed.
Reasoning steps for option B
Which processing delay matters?
Red cells remained in the uncentrifuged specimen for four hours.
What can those cells release in the tube?
Lysis can release oxyhemoglobin after collection; that possibility prevents the pigment alone from proving a pre-existing bleed.
C. Centrifugation eliminates dissolved pigments from the sample (Why this does not fit)
It sediments intact cells and separates them from the supernatant. Dissolved hemoglobin can remain in the supernatant, so a pink fluid can persist after spinning.
Reasoning steps for option C
What does centrifugation separate?
It sediments intact cells and separates them from the supernatant.
What remains despite that separation?
Dissolved hemoglobin can remain in the supernatant, so a pink fluid can persist after spinning.
D. Absence of bilirubin establishes a benign headache cause (Why this does not fit)
Appropriately timed and handled negative pigment testing can contribute to exclusion. The symptom-to-collection interval is not supplied and processing was delayed; this result cannot independently establish a benign diagnosis.
Reasoning steps for option D
Why does absent bilirubin matter in a valid pathway?
Appropriately timed and handled negative pigment testing can contribute to exclusion.
Which limitations prevent that conclusion here?
The symptom-to-collection interval is not supplied and processing was delayed; this result cannot independently establish a benign diagnosis.
Takeaway: Distinguish the pigment measured from the color seen, and include sample handling in the interpretation.
A. Centrifugation converts bilirubin into a cell pellet (Why this does not fit)
The red appearance of an intact-cell pellet and fluid discoloration can be mistaken for the same finding. It remains in the supernatant rather than being converted into a cellular pellet.
Reasoning steps for option A
Why might the pellet be confused with the pigment?
The red appearance of an intact-cell pellet and fluid discoloration can be mistaken for the same finding.
What happens to dissolved bilirubin during spinning?
It remains in the supernatant rather than being converted into a cellular pellet.
B. Severe anemia prevents all hemoglobin breakdown in CSF (Why this does not fit)
Low hemoglobin can reduce the conspicuity of blood on CT. No. Anemia does not eliminate the biochemical capacity for blood in CSF to produce breakdown products.
Reasoning steps for option B
How can anemia affect the diagnostic workup?
Low hemoglobin can reduce the conspicuity of blood on CT.
Does it abolish pigment formation from extravasated cells?
No. Anemia does not eliminate the biochemical capacity for blood in CSF to produce breakdown products.
C. A traumatic collection creates bilirubin immediately (Why this does not fit)
It introduces red cells that may later release hemoglobin. Fresh blood in a collection tube does not immediately generate the in-vivo bilirubin pattern used for this evaluation.
Reasoning steps for option C
What can fresh collection trauma introduce?
It introduces red cells that may later release hemoglobin.
Would that explain immediate bilirubin production?
Fresh blood in a collection tube does not immediately generate the in-vivo bilirubin pattern used for this evaluation.
D. Bilirubin formation from blood requires more time (Best answer)
Only a few hours have elapsed since the headache began. Cells may be present before sufficient bilirubin has formed; the negative early pigment result cannot stand alone as exclusion.
Reasoning steps for option D
What is the interval before this CSF sample?
Only a few hours have elapsed since the headache began.
Why can red cells coexist with a negative bilirubin assay?
Cells may be present before sufficient bilirubin has formed; the negative early pigment result cannot stand alone as exclusion.
Takeaway: Cells may precede detectable bilirubin; a premature negative pigment test is not a substitute for a validated diagnostic pathway.
A. Systemic bilirubin excess explains the CSF pigment (Why this does not fit)
Marked serum hyperbilirubinemia can contribute to CSF bilirubin. The serum bilirubin is within the stated range, so systemic excess is not the supported explanation here.
Reasoning steps for option A
When can circulating bilirubin confound interpretation?
Marked serum hyperbilirubinemia can contribute to CSF bilirubin.
Does the paired serum value support that explanation?
The serum bilirubin is within the stated range, so systemic excess is not the supported explanation here.
B. Fresh puncture trauma explains immediate bilirubin formation (Why this does not fit)
The needle can introduce a small amount of fresh blood. Fresh collection blood does not immediately establish the in-vivo breakdown process, especially with the compatible prior abrupt headache.
Reasoning steps for option B
Why can puncture trauma account for red cells?
The needle can introduce a small amount of fresh blood.
Can that account for bilirubin in a promptly processed sample?
Fresh collection blood does not immediately establish the in-vivo breakdown process, especially with the compatible prior abrupt headache.
C. Pigment persists after much of the intact blood has cleared (Best answer)
Blood can become less conspicuous on CT while its cells break down and are cleared. Dissolved bilirubin can remain after many intact cells disappear, supporting evaluation for an earlier subarachnoid bleed.
Reasoning steps for option C
What does the six-day interval permit?
Blood can become less conspicuous on CT while its cells break down and are cleared.
Why can the low cell count still accompany bilirubin?
Dissolved bilirubin can remain after many intact cells disappear, supporting evaluation for an earlier subarachnoid bleed.
D. Low final-tube cells place this result in the combined low-risk group (Why this does not fit)
It is below the 2,000/µL threshold used in the cited combined approach. The low-risk combination also requires absent xanthochromia; demonstrated bilirubin means that condition is not met.
Reasoning steps for option D
Why might 180 cells/µL look reassuring?
It is below the 2,000/µL threshold used in the cited combined approach.
Which required companion finding is absent?
The low-risk combination also requires absent xanthochromia; demonstrated bilirubin means that condition is not met.
Takeaway: A low red-cell count does not neutralize bilirubin evidence of an earlier bleed.
A. Patient B has a worse Hunt and Hess grade because of the clot (Why this does not fit)
The scale describes clinical condition, including consciousness and neurological deficits. Not by itself. Their described clinical findings match despite different imaging.
Reasoning steps for option A
What determines Hunt and Hess grading?
The scale describes clinical condition, including consciousness and neurological deficits.
Does the different clot burden change that examination-based grade?
Not by itself. Their described clinical findings match despite different imaging.
B. Patient B has a higher modified Fisher grade despite a similar exam (Best answer)
Patient B has both thick subarachnoid blood and intraventricular blood. The modified Fisher grades are 1 for A and 4 for B, identifying different radiographic risk despite comparable clinical descriptions.
Reasoning steps for option B
Which imaging variables differ?
Patient B has both thick subarachnoid blood and intraventricular blood.
What does that add beyond the similar examination?
The modified Fisher grades are 1 for A and 4 for B, identifying different radiographic risk despite comparable clinical descriptions.
C. Both patients have the same modified Fisher grade because they are alert (Why this does not fit)
An intact examination is clinically important for severity assessment. No. The modified scale uses blood thickness and ventricular blood rather than level of consciousness.
Reasoning steps for option C
Why might alertness seem reassuring?
An intact examination is clinically important for severity assessment.
Is alertness a component of modified Fisher grading?
No. The modified scale uses blood thickness and ventricular blood rather than level of consciousness.
D. Patient A needs less urgent aneurysm assessment because the clot is thin (Why this does not fit)
A smaller blood burden may be associated with lower risk of later complications. No. Both patients still need prompt evaluation and treatment of the bleeding source.
Reasoning steps for option D
How does less radiographic blood affect risk estimates?
A smaller blood burden may be associated with lower risk of later complications.
Does that make an untreated ruptured aneurysm nonurgent?
No. Both patients still need prompt evaluation and treatment of the bleeding source.
Takeaway: Clinical grade and radiographic blood burden are complementary, not interchangeable.
Those findings, with a mild focal deficit, fit Hunt and Hess III rather than stupor or deep coma. That combination is modified Fisher 4, independently of the clinical grade.
Reasoning steps for option A
Which clinical category includes drowsiness or confusion?
Those findings, with a mild focal deficit, fit Hunt and Hess III rather than stupor or deep coma.
Which imaging category includes thick SAH plus IVH?
That combination is modified Fisher 4, independently of the clinical grade.
B. II and 4 (Why this does not fit)
Thick subarachnoid blood with IVH does fit modified Fisher 4. Drowsiness, confusion and an arm deficit exceed a headache/meningism presentation without a deficit other than a cranial nerve palsy.
Reasoning steps for option B
Which part of this pair fits the CT?
Thick subarachnoid blood with IVH does fit modified Fisher 4.
Why does Hunt and Hess II not fit?
Drowsiness, confusion and an arm deficit exceed a headache/meningism presentation without a deficit other than a cranial nerve palsy.
C. III and 3 (Why this does not fit)
Drowsiness and confusion support Hunt and Hess III. Modified Fisher 3 is thick SAH without IVH; this patient has ventricular blood.
Reasoning steps for option C
Which part of this pair fits the examination?
Drowsiness and confusion support Hunt and Hess III.
What imaging feature prevents modified Fisher 3?
Modified Fisher 3 is thick SAH without IVH; this patient has ventricular blood.
D. IV and 2 (Why this does not fit)
Hunt and Hess IV describes stupor with more severe deficits, while modified Fisher 2 describes thin SAH with IVH. The patient follows commands with mild drift, and the cisternal clot is thick rather than thin.
Reasoning steps for option D
What clinical and imaging features would this pair require?
Hunt and Hess IV describes stupor with more severe deficits, while modified Fisher 2 describes thin SAH with IVH.
Which supplied findings conflict with those categories?
The patient follows commands with mild drift, and the cisternal clot is thick rather than thin.
Takeaway: Grade the neurological examination and CT blood pattern separately, then report both.
A. The medication is intended to dissolve the cisternal clot (Why this does not fit)
Subarachnoid blood is associated with later complications. No. Its clinical use is not thrombolysis of the blood already in the cisterns.
Reasoning steps for option A
Why might clot burden attract attention?
Subarachnoid blood is associated with later complications.
Does nimodipine function as a clot-dissolving drug?
No. Its clinical use is not thrombolysis of the blood already in the cisterns.
B. The medication is intended to seal the aneurysm neck (Why this does not fit)
The aneurysm procedure was directed at preventing further bleeding from that source. No. A calcium channel blocker does not seal an aneurysm neck.
Reasoning steps for option B
Which intervention addressed the bleeding source?
The aneurysm procedure was directed at preventing further bleeding from that source.
Can nimodipine replace that mechanical treatment?
No. A calcium channel blocker does not seal an aneurysm neck.
C. The medication is intended to normalize every arterial image (Why this does not fit)
Large-vessel spasm can contribute to delayed ischemia. No. Clinical benefit is not reliably explained by eliminating angiographic narrowing in every patient.
Reasoning steps for option C
Why might vascular narrowing seem a useful target?
Large-vessel spasm can contribute to delayed ischemia.
Is complete angiographic normalization the established measure of benefit?
No. Clinical benefit is not reliably explained by eliminating angiographic narrowing in every patient.
D. The medication is intended to improve neurological outcomes (Best answer)
It improves neurological outcomes and reduces ischemic deficits. Angiographic vasospasm and clinical ischemia are not identical outcomes, so the image alone does not establish treatment failure.
Reasoning steps for option D
What outcome supports nimodipine use after aneurysmal SAH?
It improves neurological outcomes and reduces ischemic deficits.
Why can continued narrowing coexist with benefit?
Angiographic vasospasm and clinical ischemia are not identical outcomes, so the image alone does not establish treatment failure.
Takeaway: Judge an outcome-supported therapy by its clinical purpose, not by assuming every associated imaging finding must disappear.
A. 5 mL through the gastric tube every four hours (Why this does not fit)
At 6 mg/mL, it contains 30 mg. No. The usual dose is 60 mg; the label uses a lower dose for cirrhosis, which the stem excludes.
Reasoning steps for option A
What dose does 5 mL contain?
At 6 mg/mL, it contains 30 mg.
Does that match the usual adult regimen in this stem?
No. The usual dose is 60 mg; the label uses a lower dose for cirrhosis, which the stem excludes.
B. 10 mL through the gastric tube every four hours (Best answer)
Sixty divided by 6 mg/mL is 10 mL. Yes. The oral solution may be administered enterally through the gastric tube on the usual four-hour schedule.
Reasoning steps for option B
What volume supplies a 60 mg dose?
Sixty divided by 6 mg/mL is 10 mL.
Is the gastric tube an appropriate route?
Yes. The oral solution may be administered enterally through the gastric tube on the usual four-hour schedule.
C. 10 mL through an intravenous line every four hours (Why this does not fit)
Ten milliliters contains 60 mg at the stated concentration. The oral formulation must not be administered intravenously; the permitted route is enteral.
Reasoning steps for option C
Does this volume contain the intended drug amount?
Ten milliliters contains 60 mg at the stated concentration.
Why is the plan nevertheless unsafe?
The oral formulation must not be administered intravenously; the permitted route is enteral.
D. 10 mL through the gastric tube every twelve hours (Why this does not fit)
The gastric tube is an allowed enteral route. The usual schedule is every four hours, not every twelve hours.
Reasoning steps for option D
Does this plan use an allowed route?
The gastric tube is an allowed enteral route.
Which part fails to match the prescribed regimen?
The usual schedule is every four hours, not every twelve hours.
Takeaway: Calculate the dose in milligrams and verify the route separately; an oral solution is never an intravenous formulation.
A. Enzyme induction lowers nimodipine exposure (Why this does not fit)
It accelerates metabolism and can lower nimodipine concentrations. No. Lower exposure would tend to reduce, not intensify, its blood-pressure effect.
Reasoning steps for option A
What does induction of its metabolic pathway tend to do?
It accelerates metabolism and can lower nimodipine concentrations.
Would that best explain the new hypotension after clarithromycin?
No. Lower exposure would tend to reduce, not intensify, its blood-pressure effect.
B. Impaired renal elimination increases nimodipine exposure (Why this does not fit)
It can increase exposure when the kidneys are the principal clearance route. The relevant clarithromycin interaction is inhibition of CYP3A4 metabolism; the stem supplies a new inhibitor rather than evidence of renal failure.
Reasoning steps for option B
What can impaired renal elimination do to a renally cleared drug?
It can increase exposure when the kidneys are the principal clearance route.
Does that explain this known drug combination?
The relevant clarithromycin interaction is inhibition of CYP3A4 metabolism; the stem supplies a new inhibitor rather than evidence of renal failure.
C. CYP3A4 inhibition raises nimodipine exposure (Best answer)
It is a strong CYP3A4 inhibitor and can increase nimodipine exposure. Greater exposure can intensify hypotension; the combination generally should be avoided and requires urgent medication review.
Reasoning steps for option C
How does clarithromycin affect the relevant pathway?
It is a strong CYP3A4 inhibitor and can increase nimodipine exposure.
Why does the observed pressure change follow?
Greater exposure can intensify hypotension; the combination generally should be avoided and requires urgent medication review.
D. Reduced intestinal uptake lowers nimodipine exposure (Why this does not fit)
Less absorbed drug would generally reduce systemic exposure. No. The new hypotension instead fits increased exposure from the known metabolic interaction.
Reasoning steps for option D
What would reduced uptake predict?
Less absorbed drug would generally reduce systemic exposure.
Does that fit a stronger blood-pressure effect?
No. The new hypotension instead fits increased exposure from the known metabolic interaction.
Takeaway: New hypotension after a medication addition requires an interaction check, not an assumption that the hemorrhage has progressed.
A. Create sustained hypervolemia with repeated fluid loading (Why this does not fit)
Increasing circulating volume was used to try to improve cerebral perfusion. Prophylactic or indiscriminate hypervolemia adds risk; selected pressure augmentation can address symptomatic hypoperfusion without deliberately overfilling the circulation.
Reasoning steps for option A
Why were large fluid loads historically considered?
Increasing circulating volume was used to try to improve cerebral perfusion.
Why is this not the preferred response in this euvolemic patient?
Prophylactic or indiscriminate hypervolemia adds risk; selected pressure augmentation can address symptomatic hypoperfusion without deliberately overfilling the circulation.
B. Reduce arterial pressure with an intravenous vasodilator (Why this does not fit)
Before source treatment, severe hypertension may increase concern for rebleeding. The aneurysm is secured and the demonstrated problem is symptomatic downstream hypoperfusion; reducing pressure can further impair flow.
Reasoning steps for option B
Why is pressure control important earlier in SAH?
Before source treatment, severe hypertension may increase concern for rebleeding.
What makes pressure reduction the wrong direction here?
The aneurysm is secured and the demonstrated problem is symptomatic downstream hypoperfusion; reducing pressure can further impair flow.
C. Increase nimodipine until arterial caliber returns to normal (Why this does not fit)
It is an outcome-supported medication after aneurysmal SAH. No. Angiographic normalization is not its dosing endpoint, and more drug can worsen hypotension.
Reasoning steps for option C
Why might nimodipine attract attention?
It is an outcome-supported medication after aneurysmal SAH.
Is image-normalizing dose escalation the indicated rescue strategy?
No. Angiographic normalization is not its dosing endpoint, and more drug can worsen hypotension.
D. Titrate vasopressor support to improve cerebral perfusion (Best answer)
The patient has a matching focal deficit and perfusion abnormality after several competing causes have been assessed. Specialist-guided pressure augmentation may improve perfusion through narrowed vessels while maintaining euvolemia and monitoring cardiac and neurological responses.
Reasoning steps for option D
What evidence supports symptomatic ischemia rather than narrowing alone?
The patient has a matching focal deficit and perfusion abnormality after several competing causes have been assessed.
What can selected hemodynamic treatment address?
Specialist-guided pressure augmentation may improve perfusion through narrowed vessels while maintaining euvolemia and monitoring cardiac and neurological responses.
Takeaway: Symptomatic perfusion failure after source treatment is different from an asymptomatic narrowed vessel.
A. Continue nimodipine and maintain euvolemia with surveillance (Best answer)
There is no new deficit or demonstrated perfusion failure. Continue preventive treatment and close observation rather than automatically inducing hypertension or hypervolemia.
Reasoning steps for option A
What is absent despite the narrowed vessel?
There is no new deficit or demonstrated perfusion failure.
What care follows from that distinction?
Continue preventive treatment and close observation rather than automatically inducing hypertension or hypervolemia.
B. Start prophylactic vasopressors and target hypervolemia (Why this does not fit)
Pressure and volume augmentation might appear to preempt ischemia during the risk period. The patient lacks symptomatic ischemia, and routine prophylactic augmentation exposes an otherwise stable patient to avoidable harm.
Reasoning steps for option B
Why could this plan sound protective?
Pressure and volume augmentation might appear to preempt ischemia during the risk period.
Why is it not supported for this presentation?
The patient lacks symptomatic ischemia, and routine prophylactic augmentation exposes an otherwise stable patient to avoidable harm.
C. Stop nimodipine because the artery remains narrowed (Why this does not fit)
One might assume its benefit requires disappearance of vasospasm. Its neurological benefit does not require every follow-up angiogram to normalize.
Reasoning steps for option C
Why could persistent narrowing be misread as failure?
One might assume its benefit requires disappearance of vasospasm.
What evidence supports continuing a tolerated course?
Its neurological benefit does not require every follow-up angiogram to normalize.
D. Begin antihypertensive therapy to reduce Doppler velocity (Why this does not fit)
Velocity can reflect vessel caliber, flow and other physiological conditions. Suppressing pressure to normalize velocity can reduce perfusion; the patient rather than the isolated surveillance number determines treatment.
Reasoning steps for option D
What influences Doppler velocity?
Velocity can reflect vessel caliber, flow and other physiological conditions.
Why is lowering the number not the treatment goal?
Suppressing pressure to normalize velocity can reduce perfusion; the patient rather than the isolated surveillance number determines treatment.
Takeaway: Arterial narrowing without symptoms or perfusion failure does not justify routine prophylactic pressure or volume augmentation.
A. Normal velocities establish adequate perfusion in all brain regions (Why this does not fit)
It samples blood-flow velocities in accessible vessels. Sampled velocity does not directly measure perfusion in every tissue region or exclude all mechanisms of delayed ischemia.
Reasoning steps for option A
What useful information does Doppler provide?
It samples blood-flow velocities in accessible vessels.
Why does it not establish perfusion everywhere?
Sampled velocity does not directly measure perfusion in every tissue region or exclude all mechanisms of delayed ischemia.
B. Normal velocities shift the diagnosis directly to a medication effect (Why this does not fit)
Sedatives can impair an examination after hemorrhage. No new sedative exposure is supplied, and a Doppler result does not itself diagnose medication toxicity.
Reasoning steps for option B
Why can medication effects enter the differential?
Sedatives can impair an examination after hemorrhage.
What evidence supports that explanation in this stem?
No new sedative exposure is supplied, and a Doppler result does not itself diagnose medication toxicity.
C. Normal velocities do not rule out a significant perfusion problem (Best answer)
The patient now has a focal language deficit not explained by the supplied CT or laboratory results. Urgent further evaluation, including vascular and perfusion imaging as appropriate; normal velocity sampling cannot exclude all delayed ischemic mechanisms.
Reasoning steps for option C
What has changed since surveillance?
The patient now has a focal language deficit not explained by the supplied CT or laboratory results.
What should that change prompt despite Doppler?
Urgent further evaluation, including vascular and perfusion imaging as appropriate; normal velocity sampling cannot exclude all delayed ischemic mechanisms.
D. Normal velocities identify a postictal cause of the aphasia (Why this does not fit)
A seizure and its aftermath can cause a transient language deficit. No. Doppler does not record cerebral electrical activity, so it cannot identify a postictal cause or replace evaluation of ischemia.
Reasoning steps for option D
Why are seizures part of this differential?
A seizure and its aftermath can cause a transient language deficit.
Does a normal Doppler establish that explanation?
No. Doppler does not record cerebral electrical activity, so it cannot identify a postictal cause or replace evaluation of ischemia.
Takeaway: A surveillance test never substitutes for reassessment of a new neurological deficit.
A. Urgent external ventricular CSF drainage (Best answer)
It supports hydrocephalus with an abnormal CSF pressure burden. Urgent ventricular drainage provides CSF diversion for symptomatic hydrocephalus under neurosurgical care.
Reasoning steps for option A
What does ventricular enlargement with transependymal flow indicate?
It supports hydrocephalus with an abnormal CSF pressure burden.
Which intervention addresses that burden?
Urgent ventricular drainage provides CSF diversion for symptomatic hydrocephalus under neurosurgical care.
B. Induced systemic hypertension with vasopressors (Why this does not fit)
It may be considered for selected patients with symptomatic delayed ischemia. Expanding ventricles and impaired CSF circulation require diversion rather than an assumption of vasospasm based on day 6 alone.
Reasoning steps for option B
When might pressure augmentation be useful?
It may be considered for selected patients with symptomatic delayed ischemia.
Which demonstrated problem is not corrected by that strategy?
Expanding ventricles and impaired CSF circulation require diversion rather than an assumption of vasospasm based on day 6 alone.
C. Diagnostic lumbar puncture for xanthochromia (Why this does not fit)
It can investigate a prior hemorrhage when CT is negative and puncture is safe. SAH is already established, and symptomatic pressure-related ventricular enlargement requires specialist diversion rather than an unsafe diagnostic puncture.
Reasoning steps for option C
When is diagnostic CSF pigment analysis useful?
It can investigate a prior hemorrhage when CT is negative and puncture is safe.
Why is it inappropriate for this immediate problem?
SAH is already established, and symptomatic pressure-related ventricular enlargement requires specialist diversion rather than an unsafe diagnostic puncture.
D. Endovascular balloon angioplasty of the cerebral arteries (Why this does not fit)
It may treat severe refractory arterial vasospasm in selected patients. CTA lacks major narrowing while CT demonstrates hydrocephalus, making CSF outflow the supported target.
Reasoning steps for option D
What lesion can angioplasty treat?
It may treat severe refractory arterial vasospasm in selected patients.
What imaging evidence points elsewhere?
CTA lacks major narrowing while CT demonstrates hydrocephalus, making CSF outflow the supported target.
Takeaway: Day of illness does not override demonstrated hydrocephalus; treat the abnormal CSF circulation.
A. Coiling makes new bleeding from the treated circulation implausible (Why this does not fit)
It was intended to exclude the ruptured aneurysm from circulation. Treatment reduces risk but does not make recurrent bleeding impossible; the increased blood demands reassessment.
Reasoning steps for option A
Why did coiling reduce the initial risk?
It was intended to exclude the ruptured aneurysm from circulation.
Why cannot that history dismiss the new CT?
Treatment reduces risk but does not make recurrent bleeding impossible; the increased blood demands reassessment.
B. Rebleeding requires stabilization and repeat source assessment (Best answer)
There is new or increased hemorrhage accompanying abrupt clinical decline. The team must stabilize the patient and urgently investigate the source and adequacy of vascular securement rather than presume complete protection.
Reasoning steps for option B
What does the comparison with the baseline CT establish?
There is new or increased hemorrhage accompanying abrupt clinical decline.
What must be reassessed despite prior treatment?
The team must stabilize the patient and urgently investigate the source and adequacy of vascular securement rather than presume complete protection.
C. The time course establishes delayed ischemia without further imaging (Why this does not fit)
It can cause new deficits after an aneurysmal bleed. The CT demonstrates more blood; that objective change cannot be replaced by a calendar-based ischemia diagnosis.
Reasoning steps for option C
Why is delayed ischemia part of follow-up surveillance?
It can cause new deficits after an aneurysmal bleed.
What supplied result argues for another immediate problem?
The CT demonstrates more blood; that objective change cannot be replaced by a calendar-based ischemia diagnosis.
D. Residual old blood explains the decline without a new emergency (Why this does not fit)
Existing subarachnoid blood does not disappear immediately after securement. The scan shows a substantial increase relative to the post-procedure baseline alongside abrupt deterioration.
Reasoning steps for option D
Why can blood remain visible after treatment?
Existing subarachnoid blood does not disappear immediately after securement.
What distinguishes this episode from stable residual blood?
The scan shows a substantial increase relative to the post-procedure baseline alongside abrupt deterioration.
Takeaway: Securement lowers rebleeding risk; it does not nullify evidence of a new hemorrhage.
A. Preserve the presenting pressure until the aneurysm is treated (Why this does not fit)
Adequate arterial pressure is important for cerebral perfusion. An unsecured aneurysm creates a competing rebleeding concern, so severe hypertension requires controlled assessment and treatment rather than blanket permissive hypertension.
Reasoning steps for option A
Why might preserving pressure seem protective?
Adequate arterial pressure is important for cerebral perfusion.
Why does that not justify leaving severe hypertension untreated?
An unsecured aneurysm creates a competing rebleeding concern, so severe hypertension requires controlled assessment and treatment rather than blanket permissive hypertension.
B. Use a fixed outpatient target regardless of cerebral perfusion (Why this does not fit)
They are used for long-term cardiovascular risk reduction. Intracranial pressure, the unsecured aneurysm and current perfusion alter the immediate tradeoff; abrupt pursuit of one outpatient target can be harmful.
Reasoning steps for option B
Why are outpatient pressure targets familiar?
They are used for long-term cardiovascular risk reduction.
Why is the acute SAH setting different?
Intracranial pressure, the unsecured aneurysm and current perfusion alter the immediate tradeoff; abrupt pursuit of one outpatient target can be harmful.
C. Induce hypertension before the aneurysm is secured (Why this does not fit)
Selected symptomatic delayed ischemia after source treatment may justify pressure augmentation. He has an unsecured aneurysm with severe hypertension, not a demonstrated delayed hypoperfusion syndrome requiring rescue.
Reasoning steps for option C
When might induced hypertension enter SAH care?
Selected symptomatic delayed ischemia after source treatment may justify pressure augmentation.
Why does that not fit this patient?
He has an unsecured aneurysm with severe hypertension, not a demonstrated delayed hypoperfusion syndrome requiring rescue.
D. Use titratable therapy while avoiding hypotension and large fluctuations (Best answer)
Severe hypertension can compound rebleeding concern, while excessive reduction can impair cerebral perfusion. Short-acting titratable therapy with frequent monitoring permits individualized control without claiming one universal target.
Reasoning steps for option D
Which two harms must be balanced?
Severe hypertension can compound rebleeding concern, while excessive reduction can impair cerebral perfusion.
What treatment property helps balance them?
Short-acting titratable therapy with frequent monitoring permits individualized control without claiming one universal target.
Takeaway: Before securement, avoid both severe hypertension and indiscriminate pressure reduction; titrate to the clinical setting.
A. 65 to 40 mm Hg; reducing MAP lowers perfusion pressure (Best answer)
Mean arterial pressure minus intracranial pressure is 90 minus 25, or 65 mm Hg. The difference becomes 65 minus 25, or 40 mm Hg; with ICP unchanged, cerebral perfusion pressure falls rather than improving.
Reasoning steps for option A
What is the initial pressure difference?
Mean arterial pressure minus intracranial pressure is 90 minus 25, or 65 mm Hg.
What happens after the arterial-pressure reduction?
The difference becomes 65 minus 25, or 40 mm Hg; with ICP unchanged, cerebral perfusion pressure falls rather than improving.
B. 65 to 90 mm Hg; arterial-pressure reduction improves perfusion (Why this does not fit)
The starting difference is correctly calculated as 65 mm Hg. The arterial driving pressure fell while ICP stayed fixed, so the difference decreases to 40 rather than increasing to 90.
Reasoning steps for option B
What does the initial calculation give?
The starting difference is correctly calculated as 65 mm Hg.
Why is the proposed later increase incorrect?
The arterial driving pressure fell while ICP stayed fixed, so the difference decreases to 40 rather than increasing to 90.
C. 115 to 90 mm Hg; the two pressures should be added (Why this does not fit)
The numerical sums are 115 initially and 90 afterward. The simplified relationship subtracts downstream intracranial pressure from arterial pressure instead of adding them.
Reasoning steps for option C
What would adding the measurements produce?
The numerical sums are 115 initially and 90 afterward.
Why are those sums not cerebral perfusion pressure?
The simplified relationship subtracts downstream intracranial pressure from arterial pressure instead of adding them.
D. 65 to 65 mm Hg; unchanged ICP preserves perfusion pressure (Why this does not fit)
One of the two pressures is stable. No. The arterial component decreased by 25 mm Hg, so their difference also decreases by 25.
Reasoning steps for option D
Why might unchanged ICP appear reassuring?
One of the two pressures is stable.
Does that keep their difference constant?
No. The arterial component decreased by 25 mm Hg, so their difference also decreases by 25.
Takeaway: Perfusion pressure depends on the difference between arterial and intracranial pressures, not either value alone.
A. Restrict intake to correct isolated euvolemic water retention (Why this does not fit)
Hypotonicity with concentrated urine can occur in SIADH after competing causes are excluded. Negative balance, falling weight and orthostatic tachycardia indicate clinically important volume loss.
Reasoning steps for option A
What would support a euvolemic SIADH pattern?
Hypotonicity with concentrated urine can occur in SIADH after competing causes are excluded.
Which serial findings argue against isolated euvolemic retention here?
Negative balance, falling weight and orthostatic tachycardia indicate clinically important volume loss.
B. Administer desmopressin to correct deficient antidiuresis (Why this does not fit)
Diabetes insipidus produces inappropriately dilute urine, often with rising serum sodium when water is not replaced. The urine is concentrated and serum sodium is low, so deficient antidiuresis is not the supported mechanism.
Reasoning steps for option B
What urine pattern would deficient antidiuresis produce?
Diabetes insipidus produces inappropriately dilute urine, often with rising serum sodium when water is not replaced.
How does this patient differ?
The urine is concentrated and serum sodium is low, so deficient antidiuresis is not the supported mechanism.
C. Give a loop diuretic to eliminate excess circulating volume (Why this does not fit)
Congestion or documented fluid excess could require a diuretic in an appropriate context. The patient is losing volume, so further diuresis would aggravate rather than correct the demonstrated problem.
Reasoning steps for option C
What finding could justify reducing excess volume?
Congestion or documented fluid excess could require a diuretic in an appropriate context.
What do the actual volume trends show?
The patient is losing volume, so further diuresis would aggravate rather than correct the demonstrated problem.
D. Replace sodium and intravascular volume with monitored therapy (Best answer)
Renal sodium loss is occurring with substantial net fluid loss and clinical volume depletion. Restore sodium and effective circulating volume under close monitoring while evaluating persistent natriuresis; avoid creating more hypovolemia.
Reasoning steps for option D
What do the urine and balance data indicate together?
Renal sodium loss is occurring with substantial net fluid loss and clinical volume depletion.
What immediate treatment principle follows?
Restore sodium and effective circulating volume under close monitoring while evaluating persistent natriuresis; avoid creating more hypovolemia.
Takeaway: High urine sodium does not equal SIADH; serial balance and circulation determine whether salt loss has depleted volume.
A. Renal sodium loss producing extracellular volume depletion (Why this does not fit)
Natriuresis can coexist with hypotonic hyponatremia and concentrated urine. Serial stable balance and weight without signs of depletion do not support the volume loss required for that explanation.
Reasoning steps for option A
Why can salt loss cause this laboratory pattern?
Natriuresis can coexist with hypotonic hyponatremia and concentrated urine.
What distinguishes the supplied course?
Serial stable balance and weight without signs of depletion do not support the volume loss required for that explanation.
B. Excess water intake with appropriately suppressed antidiuresis (Why this does not fit)
It should allow very dilute urine to eliminate excess water. The urine remains concentrated despite hypotonic plasma, so appropriate suppression is not demonstrated.
Reasoning steps for option B
What should suppressed antidiuresis do to the urine?
It should allow very dilute urine to eliminate excess water.
What does a urine osmolality of 550 imply here?
The urine remains concentrated despite hypotonic plasma, so appropriate suppression is not demonstrated.
C. Persistent antidiuresis despite hypotonic extracellular fluid (Best answer)
It would normally suppress antidiuresis and permit excretion of dilute urine. Concentrated urine during hypotonicity, preserved volume and exclusion of the supplied renal, endocrine and medication causes support persistent inappropriate antidiuresis.
Reasoning steps for option C
What response would low serum osmolality normally favor?
It would normally suppress antidiuresis and permit excretion of dilute urine.
Which combined findings support SIADH physiology?
Concentrated urine during hypotonicity, preserved volume and exclusion of the supplied renal, endocrine and medication causes support persistent inappropriate antidiuresis.
D. Antidiuretic hormone deficiency causing renal water loss (Why this does not fit)
The kidneys fail to conserve water and produce dilute urine. This patient has concentrated urine and low sodium rather than the typical dilute-water-loss pattern.
Reasoning steps for option D
What follows from antidiuretic hormone deficiency?
The kidneys fail to conserve water and produce dilute urine.
Why does that not explain this presentation?
This patient has concentrated urine and low sodium rather than the typical dilute-water-loss pattern.
Takeaway: Concentrated urine during hypotonicity requires interpretation alongside volume trends and endocrine, renal and medication exclusions.
A. Repeat CSF chemistry and defer antibiotics until cultures finalize (Why this does not fit)
Blood and neurosurgery can produce sterile CSF abnormalities that complicate interpretation. The documented drain, new fever and neurological decline create substantial infection concern; treatment should not await culture completion.
Reasoning steps for option A
Why might repeat chemistry be considered?
Blood and neurosurgery can produce sterile CSF abnormalities that complicate interpretation.
Why is waiting for final cultures unsafe here?
The documented drain, new fever and neurological decline create substantial infection concern; treatment should not await culture completion.
B. Obtain CSF cultures and begin vancomycin plus cefepime (Best answer)
CSF chemistry alone cannot reliably distinguish infection from postoperative or hemorrhagic inflammation, and a negative Gram stain does not exclude infection. Vancomycin plus an antipseudomonal beta-lactam covers important staphylococcal and gram-negative pathogens while cultures and specialist source-control assessment proceed.
Reasoning steps for option B
Why are cultures important despite inflammatory chemistry?
CSF chemistry alone cannot reliably distinguish infection from postoperative or hemorrhagic inflammation, and a negative Gram stain does not exclude infection.
What empirical coverage fits a suspected drain-associated infection?
Vancomycin plus an antipseudomonal beta-lactam covers important staphylococcal and gram-negative pathogens while cultures and specialist source-control assessment proceed.
C. Obtain blood cultures and begin ceftriaxone without vancomycin (Why this does not fit)
It is used against several community-acquired meningeal pathogens. CSF culture and empirical coverage for resistant staphylococci and relevant hospital gram-negative organisms are needed; ceftriaxone alone is not the standard empirical regimen.
Reasoning steps for option C
Why might ceftriaxone be familiar in meningitis care?
It is used against several community-acquired meningeal pathogens.
What is missing for this device-associated presentation?
CSF culture and empirical coverage for resistant staphylococci and relevant hospital gram-negative organisms are needed; ceftriaxone alone is not the standard empirical regimen.
D. Repeat CT angiography and begin pressor treatment for vasospasm (Why this does not fit)
It can contribute to delayed neurological deterioration during this period. A drain, high fever and inflammatory CSF warrant evaluation and treatment for infection rather than attributing the whole presentation to vasospasm.
Reasoning steps for option D
Why is vasospasm considered on day 8?
It can contribute to delayed neurological deterioration during this period.
What additional findings require another urgent pathway?
A drain, high fever and inflammatory CSF warrant evaluation and treatment for infection rather than attributing the whole presentation to vasospasm.
Takeaway: In a deteriorating patient with an EVD, culture-centered evaluation and timely empirical coverage matter more than a supposedly definitive CSF glucose or Gram stain.
A. Lumbar puncture with spectrophotometric bilirubin analysis (Why this does not fit)
It can provide evidence of a preceding bleed in an appropriate diagnostic setting. The hemorrhage is already confirmed; pigment analysis does not detect the cause of intermittent unresponsiveness.
Reasoning steps for option A
What would CSF bilirubin test?
It can provide evidence of a preceding bleed in an appropriate diagnostic setting.
Why does it not explain this remaining question?
The hemorrhage is already confirmed; pigment analysis does not detect the cause of intermittent unresponsiveness.
B. Routine repeat angiography without concurrent physiological monitoring (Why this does not fit)
CTA and perfusion imaging have not shown a new explanatory abnormality. Intermittent electrographic seizures require brain electrical monitoring rather than another vascular image alone.
Reasoning steps for option B
What vascular concern has already been assessed?
CTA and perfusion imaging have not shown a new explanatory abnormality.
Which untested episodic process is not assessed by angiography?
Intermittent electrographic seizures require brain electrical monitoring rather than another vascular image alone.
C. Continuous electroencephalographic recording during the episodes (Best answer)
Nonconvulsive seizures can cause episodic impaired responsiveness, particularly after high-grade SAH or cortical injury. Continuous EEG can capture the electrical activity during the episodes and guide treatment if seizures are detected.
Reasoning steps for option C
Why can a seizure remain possible without convulsions?
Nonconvulsive seizures can cause episodic impaired responsiveness, particularly after high-grade SAH or cortical injury.
Which investigation can connect that process to the symptoms?
Continuous EEG can capture the electrical activity during the episodes and guide treatment if seizures are detected.
D. Repeat urine sodium measurement during the episodes (Why this does not fit)
They can contribute to altered consciousness and require attention to systemic sodium and volume status. The current serum sodium is normal, while the unexplained episodic pattern and cortical injury point to a process requiring EEG assessment.
Reasoning steps for option D
Why are sodium disorders considered after SAH?
They can contribute to altered consciousness and require attention to systemic sodium and volume status.
Why is urine sodium not the best remaining test here?
The current serum sodium is normal, while the unexplained episodic pattern and cortical injury point to a process requiring EEG assessment.
Takeaway: No visible convulsions does not mean no seizures; capture an unexplained fluctuating examination with EEG when appropriate.
A. Give monitored hypertonic saline and prevent excessive correction (Best answer)
Severe hypotonic hyponatremia accompanies major neurological symptoms and a seizure. Use protocol-directed hypertonic saline with frequent reassessment and sodium measurements, aiming for initial symptom control while avoiding overly rapid correction.
Reasoning steps for option A
What makes the low sodium an emergency rather than an incidental mild value?
Severe hypotonic hyponatremia accompanies major neurological symptoms and a seizure.
What correction principle balances immediate and later risks?
Use protocol-directed hypertonic saline with frequent reassessment and sodium measurements, aiming for initial symptom control while avoiding overly rapid correction.
B. Use isotonic saline guided by volume status alone (Why this does not fit)
It can restore circulating volume when renal salt loss has produced hypovolemia. Severe neurological symptoms with marked hypotonicity require prompt controlled hypertonic treatment, alongside rather than instead of volume assessment.
Reasoning steps for option B
Why is isotonic fluid useful in some sodium disorders?
It can restore circulating volume when renal salt loss has produced hypovolemia.
What does a volume-only strategy miss in this presentation?
Severe neurological symptoms with marked hypotonicity require prompt controlled hypertonic treatment, alongside rather than instead of volume assessment.
C. Start tolvaptan to promote renal free-water excretion (Why this does not fit)
It can increase electrolyte-free water excretion in selected nonemergent water-retaining disorders. It is not the controlled initial rescue treatment for severe symptomatic hyponatremia and can cause an excessive sodium rise.
Reasoning steps for option C
What physiological effect can a vasopressin antagonist produce?
It can increase electrolyte-free water excretion in selected nonemergent water-retaining disorders.
Why is it not the preferred emergency treatment here?
It is not the controlled initial rescue treatment for severe symptomatic hyponatremia and can cause an excessive sodium rise.
D. Begin oral urea as initial sodium-directed monotherapy (Why this does not fit)
It can increase osmotic water excretion in selected patients with persistent SIADH. A seizure with profound hypotonicity requires promptly titratable emergency correction rather than an oral chronic-management strategy.
Reasoning steps for option D
In which setting can urea have a role?
It can increase osmotic water excretion in selected patients with persistent SIADH.
Why does that not make it adequate initial monotherapy here?
A seizure with profound hypotonicity requires promptly titratable emergency correction rather than an oral chronic-management strategy.
Takeaway: Treat severe symptomatic hypotonic hyponatremia promptly, but do not confuse urgent partial correction with rapid normalization.
